Gastroduodenal ulcer
Conditions
Interventions
Esomeprazole 20mg once a day for 12 months
Lansoprazole 15mg once a day for 12 months
Sponsors
National Hospital Organization
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) patients with endoscopic diagnosed as gastroduodenal ulcer scar, and continuously treated with non-steroidal anti-inflammatory drugs 2) patients accepted to registration for this study 3) patients with informed consent
Exclusion criteria
Exclusion criteria: 1) Patients with severe heart disease, acute cerebrovascular disease, hematological disease, severe liver disease, severe renal disease, or malignancy. 2) Pregnant women 3) Patients treated with Reyataz or Edulant 4) Patients with allergy for proton pump inhibitor 5) Patients with active gastroduodenal ulcers on the first time of this study 6) Patients with operative history of esophagus or stomach 7) Patients treated with steroids 8) Patients with alcoholism or drug dependence 9) Patients judged as unsuitable by investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Non-recurrent rate of gastroduodenal ulcer | — |
Countries
Japan
Contacts
Public ContactNaohiko Harada
National Hospital Organization Kyushu Medical Center Department of Gastroenterology
Outcome results
None listed